PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'London School of Hygiene & Tropical Medicine, London, UK.\', \'The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.\', \'The Phoenix Partnership (TPP), TPP House, Leeds, UK.\', \'London School of Hygiene & Tropical Medicine, London, UK; NIHR Health Protection Research Unit in Immunisation, London, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK.\', \'The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Electronic address: ben.goldacre@phc.ox.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-2600(20)30415-X10.1016/S2213-2600(20)30415-X
?:hasPublicationType
?:journal
  • The Lancet. Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 32979987
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all